Interview with Alberto Aleotti, Chairman & CEO, Menarini
After 67 years in the pharmaceutical industry, of which 45 at the head of Menarini, what would you say have been your personal keys to success? Most of my life,…
Address: Cassina Plaza, Edificio F, scala 2
Via Roma, 108 , 20060 – Cassina De’ Pecchi
Milano
Italy
Tel: +39 02 95794 1
Web: http://www.quintiles.com/
Quintiles started its activities as CRO in Italy in 1994 and now has approximately 70% of its personnel working in Milan. It offers services such as Project Management, Feasibility studies, Clinical consultancy & monitoring, Data Management & Biostatistics amongst others.It has conducted more than 100 clinical research projects (of which around 50% are local) in 1100 centres in total (more than 80% for local projects of which 20% involve phase IV and/or observational-type trials)Quintiles main operational areas in Italy are oncology, cardiovascular, internal medicine, infectious diseases, and Central Nervous System / neurological.
After 67 years in the pharmaceutical industry, of which 45 at the head of Menarini, what would you say have been your personal keys to success? Most of my life,…
Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the…
Recordati was created in 1926, and the combined work of three generations turned the small laboratory not only into a local success story but also a broad European Group. Your…
After long experience in the pharmaceutical industry, working in both multinational and local laboratories, you took the reins of the already well-established Italian subsidiary of Ferring a few months ago.…
Dr Fazi, you co-founded Eurogroup Consulting (EGC) in Italy in 2007 and are now leading a well established reality, renowned for the new model of governance it has designed. Could…
Following the successful result of the “Piano Sanitario Nazionale” 2005 – 2008, could you introduce to ours readers the key priorities and main health policies to be implemented by 2009…
Following 20 years of a comprehensive experience in diverse fields of the pharmaceutical industry, you entered Baxter in 2000. At the time, the Italian affiliate was already a well established…
Despite Italy being one of the most important pharmaceutical markets not only in Europe but also in the World, the industry remained quite stable for the last two years and…
Grunenthal-Formenti relies on Formenti’s 60 years experience in Italy and is the result of the merger of both the German and Italian entities in 96. How would you describe the…
Having led a 26 years long career in Pfizer, you have been involved in a number of different countries including leading markets such as the US and Japan, but also…
You have worked in other countries such as the UK and the US with very large and significant pharmaceutical industries. What would you say is particular about the Italian pharmaceutical…
Since 1982, CNR has been the Italian public body which most contributed to the creation of inventions and innovations. What have been the main strategies behind such a success in…
See our Cookie Privacy Policy Here
